Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think its the Market Makers trying to figure out where the support and resistance levels are. Very small trades
I originally purchased shares early this year (bought more today) and loaded up over the past month, I have an average cost of .0088.
$NEWC NEWS
New Colombia Resources to Apply for an Orphan Drug Designation With the FDA for a Medical Marijuana Pharmaceutical Drug to Treat a Rare Pediatric Disease
Marketwired
Company Subsidiary, Sannabis, Begins Medical Marijuana and Hemp Workshop at Colombia University
November 10, 2015: 08:30 AM ET
New Colombia Resources, Inc.(OTC PINK: NEWC) ("New Colombia" or the "Company"), a U.S. company with specialty metallurgical coal, medical marijuana, and hemp assets, is pleased to announce they are partnering with Advanced Imaging Projects (AiP) on the development, clinical trials, and accelerated regulatory agency approvals of a cannabinoid for multiple medical indications with a focus on treatment of a rare pediatric disease. The company and its partner are studying several indications to apply for. Once the application is submitted the designation is expected within a few months. Cannabinoid pharmaceuticals are expected to be a multi-billion dollar industry.
Advanced Imaging Projects (AiP) is a clinical stage specialty biopharmaceutical company based in South Florida that develops molecular medicines for diagnosis and treatment of oncological, neurological, and infectious diseases. They are committed to providing drugs that can enhance patient outcomes and improve quality-of-life. "AiP received several million dollars in peer reviewed competitive research grants and similarly, could anticipate support for this project from the U.S. National Institute of Health, which may also be a potential collaborator," stated Dr. Stanley Satz, PhD., Chairman and Chief Scientific Officer of Advanced Imaging Partners. "There would be great personal satisfaction in this project as I lived in Colombia for 5 years while working for the World Health Organization there," further commented Dr. Satz.
Various orphan drug designations were applied for and received by AiP from the U.S. Food and Drug Administration (FDA) for tuberculosis, pediatric neuroblastoma, Moyamoya disease and multiple system atrophy, a Parkinsonian movement disorder. These designations confer significant advantages including waiver of application filing fees, expedited approval, government grants, and reduced number of patients in clinical trials. Dr. Satz stated, "My sense is that by working together with New Colombia Resources, similarly we could obtain this for the cannabinoid under development."
Last year only three orphan drug designations were approved for rare pediatric disease, AiP received one of them. Visit http://www.orphan-drugs.org/2014/11/04/fda-orphan-drug-designations-october-2014/. Last week AiP received an approval for another orphan drug designation as well.
Dr. Satz has developed and obtained U.S. Food and Drug Administration approval for Strontium Chloride Sr89, an injectable therapeutic radiopharmaceutical for treatment of prostate and breast cancer metastatic bone pain (See Strontium or Bio-Nucleonics in the FDA Orange Book). The drug is also approved by INVIMA, Colombia's equivalent of the FDA. "After meeting with Stan, I'm convinced he is the right partner for our FDA application, doing the clinical trials in Colombia in collaboration with Universities and Government agencies will greatly reduce the costs of clinical trials," stated John Campo, Chairman and President of New Colombia Resources.
New Colombia Resources and AiP are building a team of physicians, biostatisticians, and toxicologists in preparedness of FDA trials and a pre- IND meeting.
Additionally, Sannabis began their first workshop at a major university in Colombia to set up protocols for accredited courses in Agronomic and Agro Industrial Engineering for hemp production and medical marijuana studies. Students and faculty are very interested in exploring this new industry. The next workshop will be December 4th. The first hemp crops are scheduled to be planted in January at the University. More specific details will follow in the coming weeks.
To view or purchase Sannabis products visit www.sannabis.co. Follow Sannabis on Facebook for photos and testimonials at https://www.facebook.com/sannabis.cannamedicinal
New Colombia Resources, Inc.
New Colombia Resources, Inc. is focused on the acquisition and development of high-quality metallurgical coal properties and other available resources in the Republic of Colombia. They expect to have several revenue producing businesses including; metallurgical coal mining and rock quarry aggregates for domestic Colombian highway and railroad building projects. The Company owns 100% of La Tabaquera metallurgical coal mine in Colombia with an estimated 15- 17 million tonnes of reserves. They have another pending acquisition for 390 ha and a solicitation contract for 184 ha metallurgical coal concession. New Colombia Resources also holds a significant position in Sannabis SAS which legally produces medical marijuana products in the Republic of Colombia, visit www.sannabis.co. For more information on the Company visit www.newcolombiaresources.com.
Forward Looking Statements
Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements might not occur. Factors that could cause or contribute to such differences include financing, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations. New Colombia Resources, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Top of page
I also saw a 1 share trade
I think with the low float not much stock is out there from a dollar amount that can hold this stock down with any real buying.. It appears a couple of thousand dollars moves this stock up 20%. The support seems to be building the past few days.
I agree
New Colombia Resources to Apply for an Orphan Drug Designation With the FDA for a Medical Marijuana Pharmaceutical Drug to Treat a Rare Pediatric Disease
Published: Nov 10, 2015 8:31 a.m. ET
Company Subsidiary, Sannabis, Begins Medical Marijuana and Hemp Workshop at Colombia University
SUNNY ISLES BEACH, FL and CALI, COLOMBIA, Nov 10, 2015 (Marketwired via COMTEX) -- New Colombia Resources, Inc.(otc pink:NEWC) ("New Colombia" or the "Company"), a U.S. company with specialty metallurgical coal, medical marijuana, and hemp assets, is pleased to announce they are partnering with Advanced Imaging Projects (AiP) on the development, clinical trials, and accelerated regulatory agency approvals of a cannabinoid for multiple medical indications with a focus on treatment of a rare pediatric disease. The company and its partner are studying several indications to apply for. Once the application is submitted the designation is expected within a few months. Cannabinoid pharmaceuticals are expected to be a multi-billion dollar industry.
Advanced Imaging Projects (AiP) is a clinical stage specialty biopharmaceutical company based in South Florida that develops molecular medicines for diagnosis and treatment of oncological, neurological, and infectious diseases. They are committed to providing drugs that can enhance patient outcomes and improve quality-of-life. "AiP received several million dollars in peer reviewed competitive research grants and similarly, could anticipate support for this project from the U.S. National Institute of Health, which may also be a potential collaborator," stated Dr. Stanley Satz, PhD., Chairman and Chief Scientific Officer of Advanced Imaging Partners. "There would be great personal satisfaction in this project as I lived in Colombia for 5 years while working for the World Health Organization there," further commented Dr. Satz.
Various orphan drug designations were applied for and received by AiP from the U.S. Food and Drug Administration (FDA) for tuberculosis, pediatric neuroblastoma, Moyamoya disease and multiple system atrophy, a Parkinsonian movement disorder. These designations confer significant advantages including waiver of application filing fees, expedited approval, government grants, and reduced number of patients in clinical trials. Dr. Satz stated, "My sense is that by working together with New Colombia Resources, similarly we could obtain this for the cannabinoid under development."
Last year only three orphan drug designations were approved for rare pediatric disease, AiP received one of them. Visit http://www.orphan-drugs.org/2014/11/04/fda-orphan-drug-designations-october-2014/. Last week AiP received an approval for another orphan drug designation as well.
Dr. Satz has developed and obtained U.S. Food and Drug Administration approval for Strontium Chloride Sr89, an injectable therapeutic radiopharmaceutical for treatment of prostate and breast cancer metastatic bone pain (See Strontium or Bio-Nucleonics in the FDA Orange Book). The drug is also approved by INVIMA, Colombia's equivalent of the FDA. "After meeting with Stan, I'm convinced he is the right partner for our FDA application, doing the clinical trials in Colombia in collaboration with Universities and Government agencies will greatly reduce the costs of clinical trials," stated John Campo, Chairman and President of New Colombia Resources.
New Colombia Resources and AiP are building a team of physicians, biostatisticians, and toxicologists in preparedness of FDA trials and a pre- IND meeting.
Additionally, Sannabis began their first workshop at a major university in Colombia to set up protocols for accredited courses in Agronomic and Agro Industrial Engineering for hemp production and medical marijuana studies. Students and faculty are very interested in exploring this new industry. The next workshop will be December 4th. The first hemp crops are scheduled to be planted in January at the University. More specific details will follow in the coming weeks.
To view or purchase Sannabis products visit www.sannabis.co. Follow Sannabis on Facebook for photos and testimonials at https://www.facebook.com/sannabis.cannamedicinal
New Colombia Resources, Inc.
New Colombia Resources, Inc. is focused on the acquisition and development of high-quality metallurgical coal properties and other available resources in the Republic of Colombia. They expect to have several revenue producing businesses including; metallurgical coal mining and rock quarry aggregates for domestic Colombian highway and railroad building projects. The Company owns 100% of La Tabaquera metallurgical coal mine in Colombia with an estimated 15- 17 million tonnes of reserves. They have another pending acquisition for 390 ha and a solicitation contract for 184 ha metallurgical coal concession. New Colombia Resources also holds a significant position in Sannabis SAS which legally produces medical marijuana products in the Republic of Colombia, visit www.sannabis.co. For more information on the Company visit www.newcolombiaresources.com.
Forward Looking Statements
Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements might not occur. Factors that could cause or contribute to such differences include financing, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations. New Colombia Resources, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Contact:
Company Contact:
New Colombia Resources, Inc.
John Campo
President/Chairman
(1)-410-236-8200 USA
jcampo@newcolombiaresources.com
info@newcolombiaresources.com
SOURCE: New Colombia Resources
(C) 2015 Marketwire L.P. All rights reserved.
$NEWC MAJOR NEWS: New Colombia Resources to Apply for an Orphan Drug Designation With the FDA for a Medical Marijuana Pharmaceutical Drug to Treat a Rare Pediatric Disease
http://www.marketwatch.com/story/new-colombia-resources-to-apply-for-an-orphan-drug-designation-with-the-fda-for-a-medical-marijuana-pharmaceutical-drug-to-treat-a-rare-pediatric-disease-2015-11-10
$NEWC MAJOR NEWS: New Colombia Resources to Apply for an Orphan Drug Designation With the FDA for a Medical Marijuana Pharmaceutical Drug to Treat a Rare Pediatric Disease
http://www.marketwatch.com/story/new-colombia-resources-to-apply-for-an-orphan-drug-designation-with-the-fda-for-a-medical-marijuana-pharmaceutical-drug-to-treat-a-rare-pediatric-disease-2015-11-10
MAJOR NEWS: New Colombia Resources to Apply for an Orphan Drug Designation With the FDA for a Medical Marijuana Pharmaceutical Drug to Treat a Rare Pediatric Disease
http://www.marketwatch.com/story/new-colombia-resources-to-apply-for-an-orphan-drug-designation-with-the-fda-for-a-medical-marijuana-pharmaceutical-drug-to-treat-a-rare-pediatric-disease-2015-11-10
CVSL Announces Third Quarter Results
Revenue Increased 54%; Gross Profit Increased 69.1%
http://www.prnewswire.com/news-releases/cvsl-announces-third-quarter-results-300175305.html
$NEWC 64% Strong buy on Barchart
http://www.barchart.com/quotes/stocks/NEWC
$NEWC up 25% on Friday.. Low Float, support building on the bid
$NEWC .0104 Strong buy on Barchart Very Thin !!
http://www.barchart.com/quotes/stocks/NEWC
Very thin on the ask.. It appears to be very few sellers up to 10 cents.
NEWC .0104 Barchart Strong buy Thin
http://www.barchart.com/quotes/stocks/NEWC
IMHO I think CVSL is a strong buy under $3
NEWC .0104 Thin Thin Strong buy on Barchart
http://www.barchart.com/quotes/stocks/NEWC
Looks like NEWC is being noticed!! Volume(small)but picking up!!
Appears to trade thin at these levels.
11/4/15 Brokerages Set $3.00 Target Price for CVSL (NASDAQ:CVSL)
http://dcprogressive.org/2015/11/04/brokerages-set-3-00-target-price-for-cvsl-nasdaqcvsl/
Did anyone see this 10/23/15
Penny Stock Buzzers -: HIGH PERFORMANCE (TBEV), KOC HOLDINGS AS (KHOLY), New Colombia Resources (NEWC), SWATCH GROUP AG ADR (SWGAY)
SUBMITTED BY WALLSTREETSEDGE ON OCTOBER 23, 2015 - 11:42 AM
Penny stocks, also known as cent stocks in some countries, are common shares of small public companies that trade at low prices per share. In the United States, the SEC defines a penny stock as a security that trades below $5 per share, is not listed on a national exchange, and fails to meet other specific criteria. In the United Kingdom, stocks priced under £1 are called penny shares. In the case of many penny stocks, low market price inevitably leads to low market capitalization. Such stocks can be highly volatile and subject to manipulation by stock promoters and pump and dump schemes. Such stocks present a high risk for investors, who are often lured by the hope of large and quick profits. Penny stocks in the USA are often traded over-the-counter on the OTC Bulletin Board, or Pink Sheets. In the United States, the Securities and Exchange Commission and the Financial Industry Regulatory Authority (FINRA) have specific rules to define and regulate the sale of penny stocks.
Stocks moved sharply higher over the course of the trading day on Thursday, as traders reacted to several positive catalysts. With the strong gains on the day, the major averages ended the session at their best closing levels in two months.
The major averages moved roughly sideways going into the close, hovering firmly in positive territory. The Dow soared 320.55 points or 1.9 percent to 17,489.16, the Nasdaq surged up 79.93 points or 1.7 percent to 4,920.05 and the S&P 500 jumped 33.57 points or 1.7 percent to 2,052.51.
The rally on Wall Street was partly in reaction to comments from European Central Bank President Mario Draghi signaling that the bank will consider providing further stimulus.
Economists had expected existing home sales to climb to a rate of 5.35 million from the 5.31 million originally reported for the previous month.
A separate report from the Labor Department showed that initial jobless claims rose by less than expected in the week ended October 17th.
On the earnings front, shares of McDonald’s (MCD) moved sharply higher after the fast good giant reported better than expected third quarter earnings and revenues as well as an increase in global comparable sales.
Fellow Dow components Caterpillar (CAT) and 3M (MMM) also moved to the upside after reporting their quarterly results.
HIGH PERFORMANCE (OTCMKTS:TBEV) develops, manufactures, distributes, markets, and sells sports performance drinks in the United States and Canada. It markets its products under the Throwdown name. The company was formerly known as Dethrone Royalty Holdings, Inc. and changed its name to High Performance Beverages Company in November 2013. High Performance Beverages Company was founded in 1997 and is based in Cave Creek, Arizona.
HIGH PERFORMANCE (OTCMKTS:TBEV) the stock remain unchanged $0.00090. To get a view of its performance, the one month trend of the stock was -35.71% and the three month trend remained positive 150%.
Why Should Investors Buy TBEV After The Recent Gain? Just Go Here and Find Out
KOC HOLDINGS AS (OTCMKTS:KHOLY) operates in the energy, automotive, consumer durables, finance, and other sectors worldwide. Its Energy section operates two natural gas fueled plants with a capacity of 302 MWe, as well as gas turbine-based cogeneration facilities in Istanbul, Kocaeli, and Bursa; manufactures room equipment and central air-conditioning systems, as well as electrical and gasoline-powered service cars for hotels, holiday villages.
KOC HOLDINGS AS (OTCMKTS:KHOLY) traded 0.03 million shares in the last business day while the average volume of the stock remained 0.06 million shares. The 52 week range of the stock remained $17.50-$28.64. The stock showed a positive movement of 0.88% to end at $22.95.
Has KHOLY Found The Bottom And Ready To Gain Momentum? Find Out Here
New Colombia Resources Inc (OTCMKTS:NEWC) engages in the acquisition, exploration, and development of metallurgical coal properties in Colombia. It holds a 100% interest in the La Tabaquera metallurgical coal mine in Colombia. The company was formerly known as VSUS Technologies Incorporated and changed its name to New Colombia Resources, Inc. in January 2013. New Colombia Resources, Inc. was incorporated in 2000 and is based in Sunny Isles Beach, Florida.
New Colombia Resources Inc (OTCMKTS:NEWC) reported the stock increased 147.50% and finished the day at $0.00990. The beta of the stock is recorded at 1.10 and the EPS of the stock remained -0.02. The shares outstanding of the stock are 154.34 million.
Why Should Investors Buy NEWC After the Recent Fall? Just Go Here and Find Out
SWATCH GROUP AG ADR (OTCMKTS:SWGAY) manufactures and sells finished watches, jewelry, and watch movements and components worldwide. The company’s Watches & Jewelry section produces and sells watches and jewelry. Its Electronic Systems section is involved in the design, production, and commercialization of electronic components, as well as in the sports timing products.
SWATCH GROUP AG ADR (OTCMKTS:SWGAY) the stock gain 3.39% to settle at $19.81. To get a view of its performance, the one month trend of the stock was 5.15% and the three month trend remained positive/negative -6.29%.
Why Should Investors Buy SWGAY After The Recent Gain? Just Go Here and Find Out
We combine technical analysis and fundamental research in an objective, unbiased system to help current and prospective traders and investors consistently find high-quality, high probability trading and investing ideas.
The WallStreetsEdge.com staff members are not Registered as Investment Advisors, Brokers, Dealers or as members of any research providers in any jurisdiction whatsoever.
http://wallstreetsedge.com/disclaimer/
http://www.techsonian.com/penny-stock-buzzers-high-performance-tbev-koc-holdings-as-kholy-new-colombia-resources-newc-swatch-group-ag-adr-swgay/12607126/
So it looks like I came in at the right time? I hope you are right about the blast off!!
Very small amount of shares on the ask.. $200 seems to be able to take it up 10%..
NEWC .0085 THIN THIN THIN News Today
"We have been promoting and investing in Colombia's legal medical marijuana products market for some time and believe we will grow significantly once our state of the art laboratory is completed next month. Colombia's administration should be recognized on their forward thinking and courage to right a wrong that has plagued this country for too long," said John Campo, President of New Colombia Resources. "We aim to make 'Made in Colombia' medical marijuana and hemp products the gold standard," further stated Mr. Campo.
In addition to medical marijuana products, New Colombia intends to plant hundreds of hectares of industrial hemp to cost effectively produce bio-diesel with extractors near production zones.
NEWS NEWS
Colombia Health Minister Announces Decree to Legalize Commercialization of Medical Marijuana Products
Marketwired
New Colombia Resources Inc. Is at the Forefront of This New Agro-Industry.
October 29, 2015: 09:30 AM ET
New Colombia Resources, Inc. (OTC PINK: NEWC) ("New Colombia" or the "Company"), a U.S. company with specialty metallurgical coal, medical marijuana, and hemp assets, is pleased to announce the decision of Colombia's Health Minister to allow for the manufacture and sale of medical marijuana products.
Health Minister Alejandro Gaviria stated he is working on a decree to allow for the commercialization of medical cannabis products that would legalize the elaboration and sale of phytotherapeutic products or herbal medicines that contain cannabis. "The decree is about creating the possibility to form an Agro business that sells legal marijuana products, for example ointments, creams and oils..." stated the Minister. He went on to comment that some of these products are already legally being sold.
New Colombia Resource's subsidiary, Sannabis SAS, has been legally producing medicines on the TOEZ Indian reservation for two years. This site in Norte del Cauca has ideal growing conditions and is home to some of the most sought after strains in the World. Sannabis is securing their market share for medical marijuana products by working directly with indigenous families, insuring their ability to organically produce clones of Sannabis strains, and guaranteeing the purchase of their crop every quarter. Sannabis then manufactures and packages the products on the reservation. A state of the art laboratory built to INVIMA standards is nearing completion. This lab will process hundreds of pounds of medical cannabis per day. Sannabis currently operates at gross profit margins between 250% to over 2000% on their products. These profits are reinvested in securing high quality standards for their medicines and new distribution channels.
"We have been promoting and investing in Colombia's legal medical marijuana products market for some time and believe we will grow significantly once our state of the art laboratory is completed next month. Colombia's administration should be recognized on their forward thinking and courage to right a wrong that has plagued this country for too long," said John Campo, President of New Colombia Resources. "We aim to make 'Made in Colombia' medical marijuana and hemp products the gold standard," further stated Mr. Campo.
In addition to medical marijuana products, New Colombia intends to plant hundreds of hectares of industrial hemp to cost effectively produce bio-diesel with extractors near production zones.
To view or purchase Sannabis products visit www.sannabis.co. Follow Sannabis on Facebook for photos and testimonials at https://www.facebook.com/sannabis.cannamedicinal
New Colombia Resources, Inc.
New Colombia Resources, Inc. is focused on the acquisition and development of high-quality metallurgical coal properties and other available resources in the Republic of Colombia. They expect to have several revenue producing businesses including; metallurgical coal mining and rock quarry aggregates for domestic Colombian highway and railroad building projects. The Company owns 100% of La Tabaquera metallurgical coal mine in Colombia with an estimated 15- 17 million tonnes of reserves. They have another pending acquisition for 390 ha and a solicitation contract for 184 ha metallurgical coal concession. New Colombia Resources also holds a significant position in Sannabis SAS which legally produces medical marijuana products in the Republic of Colombia, visit www.sannabis.co. For more information on the Company visit www.newcolombiaresources.com.
Forward Looking Statements
Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements might not occur. Factors that could cause or contribute to such differences include financing, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations. New Colombia Resources, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
http://money.cnn.com/news/newsfeeds/articles/marketwire/1225489.htm
Why isn't anyone on this board buying? I purchased additional shares yesterday. A small investment seems to move the stock higher and create a new level of support. If everyone agrees that under a penny is a good purchase then why is it still under a penny? How much investment dollars would it take to move past a penny and create a new support level?
http://www.barchart.com/opinions/stocks/NEWC
NEWC THIN THIN Only a 25 Million share float
Only a 25 million share float
NEWC Short Term Indicators Average: 100% Buy
http://www.barchart.com/opinions/stocks/NEWC
Only 150 million shares outstanding along with a 25 million share float.
NEWC Short Term Indicators Average: 100% Buy
http://www.barchart.com/opinions/stocks/NEWC
Only 150 million shares outstanding along with a 25 million share float.
I have made some money and lost some money... NEWC looks good to me at these levels..
NEWC Short Term Indicators Average: 100% Buy
http://www.barchart.com/opinions/stocks/NEWC
Some of the reasons I have been buying more shares of NEWC
New Colombia Resources, Inc. is focused on the acquisition and development of high-quality metallurgical coal properties in the Republic of Colombia. We own 100% of La Tabaquera coal mine in Guaduas, Colombia with an estimated 15- 17 MM tonnes of reserves, 70% metallurgical and 30% thermal coal. SGS Colombia S.A. completed a drilling program for an N.I. 43-101 Technical Report; once financing is secured we will implement the program. Our Mining Plan of Operations (PTO) was approved on December 23, 2013. In April 2014 we applied for an environmental license. We expect to begin mining operation in August 2015.
MIAMI, FL--(Marketwired - Oct 21, 2015) - New Colombia Resources, Inc. (OTC PINK: NEWC) ("New Colombia" or the "Company"), a U.S. company with specialty metallurgical coal, medical marijuana, and hemp assets, is pleased to update shareholders on the progress of their operations in Colombia. New Colombia Resources is in the final phases of the review process for an environmental permit to begin mining activities. This process has taken longer than anticipated due to additional mining plans being added that will enhance value to shareholders.
Barchart has NEWC at a Strong buy of 76%
http://www.barchart.com/quotes/stocks/NEWC
Only 150 million shares outstanding along with a 25 million share float. If there is ever significant results in the mining process and or cannabis project there isn't much in the way to 10 cents IMHO. Until more potential shareholders become aware of NEWC the price swings are expected but I hope all recent buys adding to my position will payoff.
It has to be criminal... IMHO
Thanks K... It was a costly lesson learned... The sad part is we had no chance because of the calculated dilution from the insiders. They never had any intentions to support there stcok and or there shareholders. The R/S BS is a complete scam and a money printing scenerio for them at the shareholders expense